CD4 and inflammatory bowel disease: In this study, we demonstrated that the decreased expression of JKAP in intestinal mucosa contributes to the pathogenesis of IBD, through facilitating CD4+ T-cell activation, proliferation, and Th1/Th17-cell differentiation.